EC approves Biogen's oral MS drug Tecfidera

05-02-2014 PMLiVEComments (0)

Biogen IdecEisaiNeurologicalPharmaceuticalTecfideraUSA

Almost one year after it was recommended by the European Medicines Agency (EMA) Biogen Idec's oral multiple sclerosis (MS) has been approved in the EU. Usually it takes just three months from EMA recommendation to approval from the European ...

Read more on PMLiVE

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top